Navigation Links
Avalon Pharmaceuticals to Present at the American Association for,Cancer Research 2007 Annual Meeting

GERMANTOWN, Md., April 10, 2007 /PRNewswire-FirstCall/ -- Avalon Pharmaceuticals, Inc. , today announced that AVN944 will be the subject of three poster presentations at the American Association for Cancer Research 2007 Annual Meeting to be held on April 14-18, 2007 in Los Angeles, Calif.

The first poster presented by Avalon, will review the data derived from the Avalon ongoing Phase I clinical trial of AVN944 for the treatment of hematological cancers. The poster is titled, "The Modulation of Gene Expression and Guanosine Pools by Inhibition of Inosine Monophosphate Dehydrogenase (IMPDH); correlating In Vitro Cell Resistance with Biomarker Response in Patient Samples from the Phase I Trial." This poster will provide data from clinical samples that correlate IMPDH inhibition, GTP pool suppression, and associated changes in tumor cell gene expression. The presentation will be Monday, April 16, 2007 from 8 a.m. until noon Pacific Time.

The second Avalon poster presentation is titled, "Antiangiogenic Properties of AVN944, A Potent Inhibitor of IMPDH." The poster will describe in vitro and in vivo experiments that reveal the effects of AVN944 on blood vessel formation. The presentation will be on Tuesday, April 17, 2007 from 8 a.m. until noon Pacific Time.

Another poster that will discuss AVN944 will be presented by the lab of Dr. Beverly Mitchell of Stanford University. The poster is titled, "GTP depletion induces translocation of TIF-IA and PAF53, inhibition of pre-rRNA synthesis and dislocation of nucleolar proteins." The presentation cites AVN944 as a compound that has effects on rRNA inhibition and nucleolar protein translocation. The poster presentation will be Tuesday, April 17, 2007 from 1 p.m. until 5 p.m. Pacific Time.

All three posters are in the Experimental and Molecular Therapeutics Poster Sessions.

AVN944 is an oral small molecule drug candidate that inhibits inosin
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
2. Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:8/29/2014)... 2014 Does your doctor know what you,re smoking?  ... recommended marijuana to the over 112,000 currently registered patients under ... of the other roughly 20,300+ active physicians listed with the ... it – even though a poll in February 2014 showed ... have tried it. "With marijuana legalization underway, ...
(Date:8/29/2014)... Aug. 29, 2014 Diseases largely eradicated in ... ago are returning. Measles was declared eliminated in 2000, ... as of August 15—the highest incidence in 20 years. ... department declared whooping cough a problem of "epidemic ... sick and dying from these preventable diseases—in part because ...
(Date:8/29/2014)... 29, 2014  Abaxis, Inc. (NasdaqGS: ABAX ... and consumables to the medical, research and veterinary markets, ... Chief Executive Officer, will present at the CL King ... Tuesday, September 9, 2014 at 12:30 p.m. ET. The ... Hotel in New York City . ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
... Medicare Part D beneficiaries who enter the "donut ... previously subsidized prescription costs, are twice as likely to ... more affordable or generic medications, a new study published ... (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) The study conducted by researchers ...
... The National Association of Drug Diversion Investigators ... Responsibly to Ensure Safety) Alliance (SM) have joined Attorney ... issue in Florida – prescription drug abuse. Attorney General ... a statewide Drug Take Back Day. NADDI and the ...
Cached Medicine Technology:CVS Caremark, Harvard and Brigham and Women's Researchers Say Medicare 'Donut Hole' Can Lead to a Decrease in Medication Adherence 2CVS Caremark, Harvard and Brigham and Women's Researchers Say Medicare 'Donut Hole' Can Lead to a Decrease in Medication Adherence 3NADDI and the C.A.R.E.S. Alliance Join Attorney General Bondi in Fight Against Prescription Drug Abuse 2NADDI and the C.A.R.E.S. Alliance Join Attorney General Bondi in Fight Against Prescription Drug Abuse 3
(Date:8/30/2014)... 31 August 2014: A new batteryless cardiac pacemaker ... heart motion was presented at ESC Congress 2014 ... device does not require battery replacement. , Mr ... Group at ARTORG, University of Bern, Switzerland, said: ... implants. Once they reach a critically low energy ...
(Date:8/30/2014)... (PRWEB) August 31, 2014 According to the ... step by step holistic system for skin health. It seems ... already been tried by more than 138,000 patients from all ... Mike Walden, who says that this method will not only ... clear skin. , What makes this program unique among ...
(Date:8/30/2014)... (PRWEB) August 31, 2014 In a world ... dog’ approach, Karma Web Group, LLC launches a game app ... Android the newly launched Ultimate Karma app is a colorful ... new levels of play, the game pulls double-duty by teaching ... same time. , Designed to reward gamers for consistently taking ...
(Date:8/30/2014)... NY (PRWEB) August 31, 2014 This ... and fastest growing union in New York State and ... middle-class healthcare jobs and the best quality of care ... , In recent years, thousands of healthcare workers in ... and their families by becoming members of the healthcare ...
(Date:8/30/2014)... 31, 2014 Atlanta based automotive group ... help raise money and awareness for ALS by participating ... Managers, staff, and even Vice President Jimmy Ellis all ... and can be viewed on their Youtube page; ... challenge, general managers and staff also took the opportunity ...
Breaking Medicine News(10 mins):Health News:Batteryless cardiac pacemaker is based on automatic wristwatch 2Health News:Acne No More Review Reveals Unusual Tip to Eliminate Acne Permanently 2Health News:Newly Launched Ultimate Karma App Elicits Happiness in Players and Encourages Moral Values 2Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 2Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 3Health News:This Labor Day, 1199SEIU Continues Commitment to Growing Local Economies with Good, Middle-Class Healthcare Jobs 4Health News:Jim Ellis Automotive Group Take the ALS Ice Bucket Challenge 2
... Medical Center,s Institute for Regenerative Medicine and colleagues have discovered ... how the human body regulates blood sugar levels. Reporting in ... says the protein may represent a new target for treating ... current thinking about what causes type 1 diabetes," said Bryon ...
... Journal of Clinical Oncology shows that most patients ... surgery recover an average quality of life. However, quality of ... level that remains much lower than the average population in ... that hospitals must be better at identifying this patient group. ...
... clinical research findings in peer-reviewed biomedical journals, Yale School of ... sample of trials primarily or partially funded by the National ... completing the clinical trial. These findings appear in ... which focuses on the topic of unpublished evidence. ...
... Reporter , TUESDAY, Jan. 3 (HealthDay News) -- Obese people ... risk of heart attack, stroke and death, Swedish researchers report. ... metabolic changes that occur after the surgery, such as altered ... "Bariatric surgery is associated with about 30 percent reduction ...
... News) -- Sexual satisfaction increases with age among sexually active ... don,t have sex are satisfied with their sex lives. ... planned community in the San Diego area and whose ... average age was 67 years and 63 percent of them ...
... all wounds Wound healing requires complex interactions between ... As healing progresses, the growth of new blood vessels is ... are cells that come from the bone marrow and are ... that direct their emigration from the bone marrow are unknown. ...
Cached Medicine News:Health News:Researchers discover protein that may represent new target for treating type 1 diabetes 2Health News:Impaired quality of life: A warning signal after oesophageal cancer surgery 2Health News:Many NIH-funded clinical trials go unpublished over 2 years after completion 2Health News:Weight Loss Surgery Linked to Fewer Heart Attacks, Deaths 2Health News:Weight Loss Surgery Linked to Fewer Heart Attacks, Deaths 3Health News:Women's Sexual Satisfaction Often Rises With Age: Study 2Health News:Preview of articles to be published Jan. 3, 2012 2Health News:Preview of articles to be published Jan. 3, 2012 3Health News:Preview of articles to be published Jan. 3, 2012 4Health News:Preview of articles to be published Jan. 3, 2012 5Health News:Preview of articles to be published Jan. 3, 2012 6Health News:Preview of articles to be published Jan. 3, 2012 7Health News:Preview of articles to be published Jan. 3, 2012 8
Instrument necessary for insertion of Ritleng Bicanaliculus systems and of Self-Threading Monoka systems....
... For canalicular laceration or ... silicone and Stainless Steel Probe. ... Tubing securely swaged into malleable ... anchored by punctum plug: no ...
Recommended to insert plug portion of all monocanalicular intubation systems into punctum....
Skin Tone External Eyelid Weights...
Medicine Products: